Detalhe da pesquisa
1.
A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.
Cell
; 141(4): 583-94, 2010 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-20478252
2.
Epigenetic state determines inflammatory sensing in neuroblastoma.
Proc Natl Acad Sci U S A
; 119(6)2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35121657
3.
MCU controls melanoma progression through a redox-controlled phenotype switch.
EMBO Rep
; 23(11): e54746, 2022 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36156348
4.
Corrigendum: Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance.
Nature
; 555(7695): 274, 2018 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29466340
5.
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance.
Nature
; 546(7658): 431-435, 2017 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28607484
6.
Cell state dependent effects of Bmal1 on melanoma immunity and tumorigenicity.
Nat Commun
; 15(1): 633, 2024 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38245503
7.
A distinct pattern of growth and RAC1 signaling in melanoma brain metastasis cells.
Neuro Oncol
; 25(4): 674-686, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054930
8.
Na+/H+-exchanger 1 enhances antitumor activity of engineered NK-92 natural killer cells.
Cancer Res Commun
; 2(8): 842-856, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36380966
9.
Inhibition of endothelin-B receptor signaling synergizes with MAPK pathway inhibitors in BRAF mutated melanoma.
Oncogene
; 40(9): 1659-1673, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33500549
10.
Protein Signatures of NK Cell-Mediated Melanoma Killing Predict Response to Immunotherapies.
Cancer Res
; 81(21): 5540-5554, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34518212
11.
Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy.
Nat Commun
; 12(1): 346, 2021 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33436641
12.
Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance.
Cancer Res
; 81(20): 5230-5241, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462276
13.
Mutant V600E BRAF increases hypoxia inducible factor-1alpha expression in melanoma.
Cancer Res
; 67(7): 3177-84, 2007 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17409425
14.
Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility.
Cancer Discov
; 9(1): 64-81, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30279173
15.
Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression.
Cancer Res
; 66(8): 4182-90, 2006 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16618740
16.
Distinct histone modifications denote early stress-induced drug tolerance in cancer.
Oncotarget
; 9(9): 8206-8222, 2018 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29492189
17.
Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma.
Clin Cancer Res
; 24(19): 4771-4784, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29563139
18.
Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases.
Mol Cancer Ther
; 5(5): 1136-44, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16731745
19.
A patient-derived-xenograft platform to study BRCA-deficient ovarian cancers.
JCI Insight
; 2(1): e89760, 2017 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28097235
20.
ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma.
Cancer Res
; 77(21): 5873-5885, 2017 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28887323